Report #2897673

Received May 24, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: AZ
Recovered: Unknown
Vaccinated: Apr 22, 2026
Onset: Apr 22, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	—	—

Symptoms (1)

Product preparation issue

Symptom narrative

received only the diluent component of Shingrix; received only the diluent component of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 22-APR-2026, the patient received the 1st dose of Shingrix. On 22-APR-2026, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: received only the diluent component of Shingrix) and inappropriate preparation of medication (Verbatim: received only the diluent component of Shingrix). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 18-MAY-2026 Healthcare provider wanted to know how to proceed with a patient that may have received only the diluent component of Shingrix as a first dose. The batch number was not provided upon follow- up with the reporter.